Johnson & Johnson lowers Tylenol limit
Johnson & Johnson has decided to lower the daily recommended maximum dose of Extra-Strength Tylenol.
High fiber diet may help prevent breast cancer
A fresh look at the medical evidence shows women who eat more fiber are less likely to get breast cancer, states Reuters.
Healthier vending machines
To make an effort towards a healthier change, nutritional labels will be placed on vending machine and waters may be offered at a cheaper price than sodas.
FDA review process for medical devices, unsatisfactory
The National Academy of Sciences says in an FDA-commissioned report that thousands of medical devices are allowed to go on the market without proper testing for safety. The FDA disputes the finding, reports the Los Angeles Times.
Run/Walk for Epilepsy!
The Epilepsy Foundation gears up for their 9th Annual Harrisburg Senators Family Fun Run/Walk for Epilepsy event. Everyone is invited to join the fun and make their steps count for epilepsy!
Judge backs Obama ruling on stem cell research
A U.S. judge Wednesday upheld the government rules that allow federal funding of human embryonic stem cell research, reports The Washington Post.
Breast cancer screenings may not be useful
Radiologists found tumors at a similar stage and size whether or not they used computer-aided detection software to study mammograms, reports the Los Angeles Times.
Healthcare law challenge hopes to get hearing
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election, reports the New York Times.
Thomas Jefferson University president Barchi leaving
The president of Thomas Jefferson University, Robert L. Barchi, said Wednesday he will step down at the end of his current term in June 2012.
Penn medical school to create orphan drug center with $10M gift
Penn received a $10 million gift from an anonymous donor that will be used to create an interdisciplinary center focused on discovering novel treatments for rare “orphan” diseases.